These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 16939734

  • 1. Revisiting steroids in the primary treatment of acute Kawasaki disease.
    Burns JC.
    J Pediatr; 2006 Sep; 149(3):291-2. PubMed ID: 16939734
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of Kawasaki disease.
    Taddio A, Rosé CD.
    N Engl J Med; 2007 Jun 28; 356(26):2747; author reply 2748. PubMed ID: 17600908
    [No Abstract] [Full Text] [Related]

  • 3. Adverse effects of methylprednisolone pulse therapy in refractory Kawasaki disease.
    Miura M, Ohki H, Yoshiba S, Ueda H, Sugaya A, Satoh M, Yamagishi H.
    Arch Dis Child; 2005 Oct 28; 90(10):1096-7. PubMed ID: 16177169
    [No Abstract] [Full Text] [Related]

  • 4. High-dose aspirin in Kawasaki disease.
    Shulman ST.
    J Pediatr; 1999 Apr 28; 134(4):523-4. PubMed ID: 10190936
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of Kawasaki disease with corticosteroid.
    Shulman ST, Rowley AH.
    J Pediatr; 1996 Sep 28; 129(3):483; author reply 484-5. PubMed ID: 8804349
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
    Pediatrics; 2004 Dec 28; 114(6):e689-93. PubMed ID: 15545617
    [Abstract] [Full Text] [Related]

  • 7. Arthritis in Kawasaki disease after responding to intravenous immunoglobulin treatment.
    Lee KY, Oh JH, Han JW, Lee JS, Lee BC.
    Eur J Pediatr; 2005 Jul 28; 164(7):451-2. PubMed ID: 15782294
    [No Abstract] [Full Text] [Related]

  • 8. Clinical and epidemiological characteristics of children with Kawasaki disease in Turkey.
    Ozdemir H, Ciftçi E, Tapisiz A, Ince E, Tutar E, Atalay S, Dogru U.
    J Trop Pediatr; 2010 Aug 28; 56(4):260-2. PubMed ID: 20007257
    [Abstract] [Full Text] [Related]

  • 9. Myocardial infarction associated with Kawasaki disease in adult man: case report and review of literature.
    Serpytis P, Petrulioniene Z, Gargalskaite U, Gedminaite A, Panaviene V.
    Am J Med; 2015 Mar 28; 128(3):e1-3. PubMed ID: 25446304
    [No Abstract] [Full Text] [Related]

  • 10. [Reply to questions regarding diagnosis and treatment of Kawasaki disease].
    Wang HW.
    Zhonghua Er Ke Za Zhi; 2006 May 28; 44(5):337-8. PubMed ID: 16780708
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin.
    Dale RC, Saleem MA, Daw S, Dillon MJ.
    J Pediatr; 2000 Nov 28; 137(5):723-6. PubMed ID: 11060542
    [Abstract] [Full Text] [Related]

  • 12. Primary treatment of incomplete Kawasaki disease with infliximab and methylprednisolone in a patient with a contraindication to intravenous immune globulin.
    Shirley DA, Stephens I.
    Pediatr Infect Dis J; 2010 Oct 28; 29(10):978-9. PubMed ID: 20431427
    [Abstract] [Full Text] [Related]

  • 13. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
    Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W, Vetter VL, Atz AM, Li JS, Takahashi M, Baker AL, Colan SD, Mitchell PD, Klein GL, Sundel RP, Pediatric Heart Network Investigators.
    N Engl J Med; 2007 Feb 15; 356(7):663-75. PubMed ID: 17301297
    [Abstract] [Full Text] [Related]

  • 14. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
    Arch Dis Child; 2008 Feb 15; 93(2):142-6. PubMed ID: 17962370
    [Abstract] [Full Text] [Related]

  • 15. An Uncommon Complication of a Common Disease: Pneumatosis Intestinalis in an Infant with Kawasaki Disease.
    Ferstenfeld I, Shemer A, Razon Y, Yeshayahu Y.
    Isr Med Assoc J; 2019 Nov 15; 21(11):763-765. PubMed ID: 31713369
    [No Abstract] [Full Text] [Related]

  • 16. Is there a role for corticosteroids in Kawasaki disease?
    Shulman ST.
    J Pediatr; 2003 Jun 15; 142(6):601-3. PubMed ID: 12838185
    [No Abstract] [Full Text] [Related]

  • 17. High-dose aspirin for Kawasaki disease: outdated myth or effective aid?
    Amarilyo G, Koren Y, Brik Simon D, Bar-Meir M, Bahat H, Helou MH, Mendelson A, Hezkelo N, Chodick G, Berkun Y, Eisenstein E, Butbul Aviel Y, Barkai G, Bolkier Y, Padeh S, Brik R, Hashkes PJ, Harel L, Uziel Y.
    Clin Exp Rheumatol; 2017 Jun 15; 35 Suppl 103(1):209-212. PubMed ID: 28079513
    [Abstract] [Full Text] [Related]

  • 18. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
    Ogata S, Ogihara Y, Honda T, Kon S, Akiyama K, Ishii M.
    Pediatrics; 2012 Jan 15; 129(1):e17-23. PubMed ID: 22144699
    [Abstract] [Full Text] [Related]

  • 19. Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications.
    De Rosa G, Pardeo M, Rigante D.
    Eur Rev Med Pharmacol Sci; 2007 Jan 15; 11(5):301-8. PubMed ID: 18074939
    [Abstract] [Full Text] [Related]

  • 20. Cyclosporin rapidly diminished a severe lupus-associated macrophage association syndrome refractory to pulsed methylprednisolone and intravenous immunoglobulin.
    Takizawa Y, Maruyama J, Setoguchi K.
    Scand J Rheumatol; 2009 Jan 15; 38(6):492-4. PubMed ID: 19922027
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.